Company Overview of Elsevier B.V.
Elsevier B.V. publishes science, health, and technology online and offline literature. It publishes books, periodicals, journals, and Web based digital solutions in the areas of business/management science/accounting, chemistry, computer science/security, criminal justice, earth and environmental sciences, economics/finance, energy/power, engineering, life sciences, materials science, mathematics and statistics, media technology, physics and astronomy, psychology, security, and social sciences. It offers Elsevier Clinical Solutions, an evidence-based clinical decision solution that provides solutions in the areas of academic education, clinical practice, drug information, patient engagement,...
Amsterdam, 1043 NX
Founded in 1880
Key Executives for Elsevier B.V.
Executive Vice President of Operations
Managing Director for Clinical Decision Support Group and President of Clinical Solutions Business
Senior Vice President and General Counsel
Compensation as of Fiscal Year 2015.
Elsevier B.V. Key Developments
Elsevier Delivers Data Insights to Help Improve Phase I and Phase II Clinical Trials with Launch of PharmaPendium Efficacy Module
Oct 1 15
Elsevier announced the launch of a new module in PharmaPendium, its fully searchable database of drug approval documents and extracted data to inform critical drug development decisions. The PharmaPendium Efficacy Module features over 1.4 million extracted efficacy observations from FDA and EMA drug approval packages, providing insights to researchers to support clinical development decisions and clinical trial design. The failure rates for Phase I and Phase II clinical trials range from 35% to 57%; a lack of efficacy is common reasons for continued late-stage trial failures, followed by a lack of drug safety. The data in the PharmaPendium Efficacy Module helps researchers to improve translational research which enables researchers to predict human outcomes with greater confidence, resulting in more informed clinical trial study designs. The PharmaPendium Efficacy Module helps researchers quickly find relevant comparative information by enabling them to search on an indication and/or endpoint of interest. It features the most in-depth efficacy database on FDA and EMA approved drugs, where information such as indication tested, sample size, primary or secondary endpoints, study design, and age groups, can be easily searched and filtered on to get critical insights which can improve clinical trial design and mitigate the risk of clinical failure. PharmaPendium offers dedicated data modules that provide insights and information on the critical focused areas of drug development including drug safety, ADME and drug-drug interactions and contains text searchable source documents; FDA and EMA drug approval documents; FDA AERS; FDA advisory committee meetings and selected journals.
Elsevier to Introduce Next-Generation Learning Solution at National League for Nursing Education Summit 2015
Sep 29 15
Elsevier announced that it will unveil its new, next-generation learning solution at the National League for Nursing (NLN) Education Summit, Sept. 30 - Oct. 2, in Las Vegas. The nursing education, Sherpath uses data, analytics and adaptive techniques to track students' interactions with content, assessments and simulations while providing a highly focused learning path for each student. Sherpath empowers faculty to easily customize the learning modules to their specific course outcomes. Programs will now have real-time, learning analytics to monitor their program against accrediting body standards and student success towards licensure. Developed by Elsevier Education experts using original research with students and instructors, Sherpath addresses the current needs at the educator, student and program levels. It is a learning suite that integrates digital learning materials and the technology necessary to ensure nursing education program success for students, instructors and institutions. With a seamless, responsive and optimized platform, Sherpath provides a tailored learning path at the individual level, guiding the student to success on formative and summative assessments and ensuring a simple and engaging process of genuine learning.
Elsevier's Reviewer Recognition Platform Expands its Functionality
Sep 3 15
Elsevier announced that its Reviewer Recognition platform has launched a new functionality which enables reviewers to list their entire review history, including their reviews for non-Elsevier journals, in one place online. It also allows them to share their Reviewer Page publically - increasing visibility and recognition of their work. Through the Reviewer Recognition platform, Elsevier reviewers already have access to a personal review profile page in which they can view their Elsevier journal review history. The new functionality now also allows reviewers to list their peer review activities for all journals, regardless of publisher or whether the reviewed manuscript was finally published, and to share this list publically. In doing so, Elsevier will fully respect confidentiality around the peer review process. Other features available for reviewers of Elsevier titles via the Reviewer Recognition platform are: Reviewer status based on number of reviews; An annual review history report; Reviewer discounts on book and author services purchases; Certificates based on review history; and Option to volunteer to review for more journals.
Similar Private Companies By Industry
Recent Private Companies Transactions